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Background
Whether arthroscopic partial meniscectomy for symptomatic patients with a menis-
cal tear and knee osteoarthritis results in better functional outcomes than nonop-
erative therapy is uncertain.
Methods
We conducted a multicenter, randomized, controlled trial involving symptomatic pa-
tients 45 years of age or older with a meniscal tear and evidence of mild-to-moderate 
osteoarthritis on imaging. We randomly assigned 351 patients to surgery and postop-
erative physical therapy or to a standardized physical-therapy regimen (with the option 
to cross over to surgery at the discretion of the patient and surgeon). The patients were 
evaluated at 6 and 12 months. The primary outcome was the difference between the 
groups with respect to the change in the Western Ontario and McMaster Universities 
Osteoarthritis Index (WOMAC) physical-function score (ranging from 0 to 100, with 
higher scores indicating more severe symptoms) 6 months after randomization.
Results
In the intention-to-treat analysis, the mean improvement in the WOMAC score after 
6 months was 20.9 points (95% confidence interval [CI], 17.9 to 23.9) in the surgical 
group and 18.5 (95% CI, 15.6 to 21.5) in the physical-therapy group (mean difference, 
2.4 points; 95% CI, −1.8 to 6.5). At 6 months, 51 active participants in the study who 
were assigned to physical therapy alone (30%) had undergone surgery, and 9 patients 
assigned to surgery (6%) had not undergone surgery. The results at 12 months were 
similar to those at 6 months. The frequency of adverse events did not differ sig-
nificantly between the groups.
Conclusions
In the intention-to-treat analysis, we did not find significant differences between the 
study groups in functional improvement 6 months after randomization; however, 
30% of the patients who were assigned to physical therapy alone underwent surgery 
within 6 months. (Funded by the National Institute of Arthritis and Musculoskeletal 
and Skin Diseases; METEOR ClinicalTrials.gov number, NCT00597012.)
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Symptomatic, radiographically con-firmed osteoarthritis of the knee affects more than 9 million people in the United 
States.1 Meniscal tears are also highly prevalent, 
with imaging evidence of a meniscal tear ob-
served in 35% of persons older than 50 years of 
age; two thirds of these tears are asymptomatic.2 
Meniscal damage is especially prevalent among 
persons with osteoarthritis3,4 and is frequently 
treated surgically with arthroscopic partial men-
iscectomy. This procedure, in which the surgeon 
trims the torn meniscus back to a stable rim, is 
performed for a range of indications in more than 
465,000 persons annually in the United States.5
The high prevalence of meniscal tears in pa-
tients with osteoarthritis of the knee and the 
observation that these lesions are often asymp-
tomatic challenge the ability of clinicians to de-
termine whether symptoms are caused by the 
tear, osteoarthritis, or both. Clinicians who sus-
pect that the tear is symptomatic may refer the 
patient to a surgeon for arthroscopic partial men-
iscectomy. The role of arthroscopic surgery in 
patients with osteoarthritis has been studied in 
two randomized, controlled trials over the past 
decade. One trial6 compared arthroscopic dé-
bridement and lavage with a sham surgical pro-
cedure, and the other7 compared arthroscopic 
débridement with a nonoperative regimen. Nei-
ther trial showed a statistically significant or 
clinically important difference between the ar-
throscopic and nonoperative groups with respect 
to functional improvement or pain relief over a 
period of 24 months.6,7
These landmark trials established that ar-
throscopic treatment was not superior to the 
other interventions in the treatment of knee os-
teoarthritis, but they did not focus on manage-
ment of a symptomatic meniscal tear, which is a 
frequent indication for knee arthroscopy in pa-
tients with osteoarthritis of the knee. The effi-
cacy of arthroscopic partial meniscectomy in 
symptomatic patients with a meniscal tear and 
osteoarthritis has been evaluated, to our knowl-
edge, in only one randomized, controlled trial, 
which was a single-center study involving 90 pa-
tients.8,9 This study did not show a significant 
difference in pain relief or functional status be-
tween arthroscopic partial meniscectomy plus a 
physical-therapy regimen and physical therapy 
alone. Given the frequency and cost of arthroscop-
ic partial meniscectomy and the paucity of data, 
we designed the Meniscal Tear in Osteoarthritis 
Research (METEOR) trial to assess the efficacy of 
arthroscopic partial meniscectomy as compared 
with a standardized physical-therapy regimen for 
symptomatic patients with a meniscal tear and 
concomitant mild-to-moderate osteoarthritis.
Me thods
Study Design and Oversight
This randomized, controlled trial was conducted 
in seven U.S. tertiary referral centers. Details of 
the trial design and conduct have been published 
elsewhere.10 The study was approved by the Part-
ners HealthCare Human Research Committee and 
overseen by a data and safety monitoring board 
assembled by the National Institute of Arthritis 
and Musculoskeletal and Skin Diseases. There 
was no commercial sponsorship of this trial. The 
first and last authors vouch for the accuracy of 
the reported data and analyses and the adherence 
of the study to the protocol; the protocol and the 
statistical analysis plan are available with the full 
text of this article at NEJM.org.
Enrollment and Randomization
We enrolled symptomatic patients 45 years of age 
or older with a meniscal tear as well as osteoar-
thritis detected on magnetic resonance imaging 
(MRI) or radiography. Since osteoarthritis-defin-
ing features can be seen on MRI before changes 
consistent with osteoarthritis can be detected on 
radiography, patients with normal findings on 
radiography and cartilage defects on MRI were 
eligible. We required that patients have at least one 
symptom that was consistent with a meniscal 
tear11 that had persisted for at least 1 month de-
spite pharmacologic treatment, physical therapy, 
or limitation of activity. Detailed entry and exclu-
sion criteria (including specific symptoms that were 
consistent with a meniscal tear) are provided in 
Table 1 in the Supplementary Appendix, available 
at NEJM.org.
Research coordinators at each center reviewed 
outpatient schedules to identify patients who were 
potentially eligible to participate in the study. 
The surgeon assessed eligibility criteria and re-
ferred eligible patients to the research coordina-
tor, who introduced the study using a standard-
ized script. Surgeons and coordinators told patients 
randomly assigned to physical therapy alone that 
they would have the opportunity to cross over to 
The New England Journal of Medicine 
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arthroscopic partial meniscectomy over time if 
the patient and surgeon thought it was clinically 
indicated. Patients who wished to participate pro-
vided written informed consent and completed a 
baseline questionnaire.
Patients were then randomly assigned in a 1:1 
ratio to a treatment group with the use of a secure 
program on the trial website. Randomization was 
conducted in blocks of varying size within each 
site, stratified according to sex and the extent of 
osteoarthritis on baseline radiography (either 
Kellgren–Lawrence grade 0 to 2 [no joint-space 
narrowing] or Kellgren–Lawrence grade 3 [≤50% 
joint-space narrowing]).
After randomization, the patient was informed 
about the treatment assignment; the surgeon was 
informed as part of the surgical booking pro-
cess. Treatment was generally scheduled within 
2 to 4 weeks after randomization.
Interventions
Teams of surgeon investigators met in person on 
two occasions and regularly by telephone confer-
ence call throughout enrollment, as did teams of 
physical therapists. These teams developed stan-
dardized surgical and physical-therapy interven-
tions that were implemented in all study centers. 
Standardization was developed further in telephone 
conference calls and meetings with the use of 
case examples. All surgeons were fellowship-
trained and performed at least 50 arthroscopic 
partial meniscectomies annually. Most of the 
therapists were board-certified.
Arthroscopic Partial Meniscectomy
The protocol called for surgeons to perform an 
arthroscopic partial meniscectomy by trimming 
the damaged meniscus back to a stable rim. Sur-
geons removed loose fragments of cartilage and 
bone, but this procedure did not involve penetra-
tion of the subchondral bone. Preoperative anti-
biotics were used routinely. Postoperatively, pa-
tients were allowed to bear weight as they were 
able. Bracing was not used. Patients were referred 
to a physical therapist for a postoperative stan-
dardized physical-therapy program with the use 
of the same protocol as that used in the physical-
therapy group, described below.
Physical Therapy
The physical-therapy protocol was developed by a 
team of experienced physical therapists. The pro-
tocol was based on literature supporting the ef-
fectiveness of land-based, individualized physical 
therapy with progressive home exercise for pa-
tients with knee osteoarthritis.10,12,13 The three-
stage structured program was designed to ad-
dress inflammation, range of motion, concentric 
and eccentric muscle strength, muscle-length re-
strictions, aerobic conditioning (e.g., with the 
use of a bicycle, elliptical machine, or treadmill), 
functional mobility, and proprioception and bal-
ance. Details of the physical-therapy program are 
described in Table 2 in the Supplementary Ap-
pendix. Criteria for advancing from stage I to II 
and from stage II to III included the level of self-
reported pain, observed strength, range of knee 
motion, knee effusion, and functional mobility. 
At each stage, it was recommended that the pa-
tient attend physical-therapy sessions once or 
twice weekly and perform exercises at home. Pa-
tients progressed at their own pace; the duration 
of participation varied depending on the pace of 
improvement. Generally, the program lasted about 
6 weeks.
In both the arthroscopic-partial-meniscectomy 
and physical-therapy groups, patients were permit-
ted to receive acetaminophen and nonsteroidal 
antiinflammatory agents as needed. Intraarticular 
injections of glucocorticoids were permitted over 
the course of the trial.
Outcomes
The primary outcome was the difference between 
the study groups with respect to the change in the 
score on the physical-function scale of the West-
ern Ontario and McMaster Universities Osteoar-
thritis Index (WOMAC)14 from baseline to 6 months 
after randomization. WOMAC scores range from 
0 to 100, with higher scores indicating worse phys-
ical function. The original statistical-analysis plan 
referred to the primary outcome as the WOMAC 
function score at 6 months, with adjustment for 
the baseline score. However, since the change in 
the WOMAC physical-function score is a stan-
dard outcome in assessing interventions for knee 
osteoarthritis and is more easily interpreted than 
the raw score at 6 months adjusted for the base-
line score, we revised the primary outcome before 
analyzing the trial data. We specified 6 months as 
the time for assessment of the primary outcome 
because the clinical response to treatment is appar-
ent by this time. We added a 12-month assessment 
to determine whether the response was stable.
The New England Journal of Medicine 
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Secondary outcomes were the pain score on 
the Knee Injury and Osteoarthritis Outcome Scale 
(KOOS), which has been used frequently in stud-
ies involving patients with a meniscal tear,15,16 
and the score on the physical-activity scale of the 
Medical Outcomes Study 36-Item Short-Form 
Health Survey (SF-36). Scores on both scales range 
from 0 to 100, with higher KOOS scores indicat-
ing more severe pain and higher SF-36 scores 
indicating greater physical activity.17 We also con-
sidered a binary outcome that was defined as 
improvement in the WOMAC physical-function 
score of at least 8 points (a clinically relevant 
difference specified a priori10,18,19) without cross-
over to the other study group.
Assessments
Questionnaires were administered at baseline and 
3, 6, and 12 months after randomization. The 
primary outcome was assessed at 6 months, with 
the 3-month and 12-month assessments used to 
capture the trajectory and stability of the treat-
ment response. Site coordinators contacted the 
participants by telephone every other week for 
the first 3 months after randomization and quar-
terly thereafter to ascertain adverse events and 
compliance with physical therapy. Surgeons, pa-
tients, and research staff were aware of the treat-
ment assignments.
Radiographs of the weight-bearing knee were 
assessed at each study site by the participating 
surgeon on the basis of the Kellgren–Lawrence 
grade20 and were then reassessed centrally (also on 
the basis of the Kellgren–Lawrence grade)21 by a 
musculoskeletal radiologist. The concordance be-
tween these readings was 71.8%. Readings per-
formed at the clinical site were used for assess-
ing eligibility and randomization strata, whereas 
central readings were used in the analysis. Analy-
ses performed with readings at the clinical site 
did not materially differ from those performed 
with central readings.
Statistical Analysis
The primary analysis was implemented with an 
analysis of covariance with changes in the 
WOMAC physical-function score from baseline to 
6 months as the dependent variable, treatment as 
the independent variable of interest, and study 
site as a covariate. Other covariates, such as age, 
sex, and baseline Kellgren–Lawrence grade, were 
balanced across groups and were therefore not 
included in the analysis. The primary analysis 
used a modified intention-to-treat approach in 
which patients who did not withdraw from the 
351 Underwent randomization
14,430 Patients were assessed
for eligibility
14,079 Did not undergo randomi-
zation
1,092 Were not screened by
physician




2691 Did not have MRI
2198 Had patellofemoral
disorder
1816 Had grade 4 on
Kellgren–Lawrence 
scale
1613 Had other reasons
195 Were eligible, but were
not referred
784 Were eligible, but declined 
to participate
283 Had preference for
APM
166 Had preference for PT
335 Had other reason
174 Were assigned to APM 177 Were assigned to PT






161 Were evaluated in 6-mo follow-up
9 Did not undergo APM





2 Were lost to follow-up
169 Were evaluated in 6-mo follow-up
51 Crossed over and underwent APM






1 Was lost to follow-up
156 Were evaluated in 12-mo follow-up
9 Did not undergo APM





2 Were lost to follow-up
164 Were evaluated in 12-mo follow-up







AUTHOR, PLEASE NOTE: 










Figure 1. Trial Enrollment and Follow-up.
APM denotes arthroscopic partial meniscectomy, M I magnetic resonance 
imaging, PT physical therapy, and TKR total knee replacement.
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study were evaluated in the group to which they 
were randomly assigned. We performed three sec-
ondary analyses: an analogous intention-to-treat 
analysis of covariance with the use of either the 
KOOS pain score or the SF-36 physical-activity 
score as the dependent variables and a logistic 
regression, with adjustment for the study site, 
which used the binary outcome defined above. We 
prespecified one subgroup analysis based on the 
baseline radiographic grade (Kellgren–Lawrence 
grade 0 to 2 vs. Kellgren–Lawrence grade 3).10,22 
Additional analyses with adjustment for uncer-
tainty due to missing data are described in the 
Supplementary Appendix.23
We powered the study to detect a 10-point dif-
ference in the WOMAC physical-function score 
between the arthroscopic-partial-meniscectomy 
and physical-therapy groups. This was the dif-
ference we noted in observational pilot data, and 
it is close to the minimal clinically important 
difference in the WOMAC physical-function 
score among patients with osteoarthritis.18,19 On 
the basis of a type I error rate of 5% and a 
power of 80%, and taking into account potential 
losses to follow-up and crossovers from the as-
signed group to the other group before the as-
sessment of the primary outcome, we set the 
target sample size at 340 patients.
R esult s
Characteristics of the Study Population
From June 2008 through August 2011, a total of 
14,430 patients were screened in seven study cen-
ters, of whom 1330 (9.2%) were eligible. Of these 
patients, 351 (26.4%) were enrolled and randomly 
assigned to a treatment group (Fig. 1). The two 
groups were similar with respect to age, sex, race 
or ethnic group, baseline Kellgren–Lawrence grade 
of radiographic severity, and baseline WOMAC 
physical-function score (Table 1).
Outcomes
In the intention-to-treat analysis that was adjusted 
for the study site, the mean improvement in the 
WOMAC physical-function score from baseline 
to 6 months was 20.9 points in the group ran-
domly assigned to arthroscopic partial menis-
cectomy, as compared with 18.5 points in the 
physical-therapy group (between-group differ-
ence, 2.4 points; 95% confidence interval [CI], 
−1.8 to 6.5) (Table 2 and Fig. 2A). Results of the 
analysis (as originally specified) of the 6-month 
WOMAC physical-function score, adjusted for the 
baseline score, likewise did not show a clinically 
important or statistically significant difference 







Mean age — yr 59.0±7.9 57.8±6.8
Sex — no. (%)
Male 71 (44.1) 72 (42.6)
Female 90 (55.9) 97 (57.4)
Race or ethnic group — no. (%)†
White 138 (85.7) 142 (84.0)
Black 15 (9.3) 17 (10.1)
Hispanic 2 (1.2) 5 (3.0)
Other 6 (3.7) 5 (3.0)
Index knee — no. (%)
Right 70 (43.5) 68 (40.2)
Left 91 (56.5) 101 (59.8)
Mean body-mass index 30.0±6.1 30.0±6.1
WOMAC physical-function score‡ 37.1±17.9 37.5±18.3
KOOS pain score§ 46.0±15.5 47.2±16.4
Mental Health Index 5 score¶ 74.8±12.9 74.0±13.9
SF-36 physical-activity score‖ 44.3±23.7 43.3±23.3
Kellgren–Lawrence grade — no. (%)**
0 34 (21.1) 36 (21.3)
1 26 (16.1) 35 (20.7)
2 37 (23.0) 39 (23.1)
3 45 (28.0) 39 (23.1)
* Plus–minus values are means ±SD. There were no significant differences be-
tween the groups. Percentages may not sum to 100 because of rounding. 
The body-mass index is the weight in kilograms divided by the square of the 
height in meters.
† Race and ethnic group were self-reported.
‡ Scores on the physical-function subscale of the Western Ontario and 
McMaster Universities Osteoarthritis Index (WOMAC) range from 0 to 100, 
with higher scores indicating more limitation of physical function.
§ Scores on the pain scale of the Knee Injury and Osteoarthritis Outcome 
Scale (KOOS) range from 0 to 100, with higher scores indicating more pain.
¶ Scores on the Mental Health Index 5 range from 0 to 100, with higher scores 
indicating better mental health.
‖ Scores on the physical-activity scale of the Medical Outcomes Study 36-Item 
Short-Form Health Survey (SF-36) range from 0 to 100, with higher scores 
indicating greater physical activity.
** A Kellgren–Lawrence grade of 0 (no osteophytes or joint-space narrowing) 
indicates no osteoarthritis, a grade of 1 (questionable osteophyte) indicates 
possible osteoarthritis; a grade of 2 (definite osteophyte, no joint-space nar-
rowing) indicates mild osteoarthritis, a grade of 3 (≤50% joint-space nar-
rowing) indicates moderate osteoarthritis, and a grade of 4 (>50% joint-
space narrowing) indicates severe osteoarthritis. In 11.8% of patients, 
Kellgren–Lawrence grades were not assessed centrally.
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between groups (difference, 3.4 points; 95% CI, 
−0.04 to 6.8). In the intention-to-treat analysis of 
the KOOS pain score, the mean decreases (i.e., 
improvements) from baseline to 6 months were 
24.2 points in patients assigned to arthroscopic 
partial meniscectomy versus 21.3 points in those 
assigned to physical therapy alone (between-
group difference, 2.9 points; 95% CI, −1.2 to 7.0) 
(Table 2 and Fig. 2B). In intention-to-treat analy-
ses of 12-month outcomes adjusted for study site, 
the two groups had similar changes from base-
line in the WOMAC physical-function and KOOS 
pain scores (Table 2).
Among 330 active participants in the study, by 
6 months of follow-up, 51 patients assigned to 
physical therapy alone (30.2%) had undergone 
arthroscopic partial meniscectomy, whereas 9 pa-
tients assigned to surgery (5.6%) had not under-
gone the procedure. An additional 8 active pa-
tients in the study (4.7%) who were assigned to 
the physical-therapy group crossed over to ar-
throscopic partial meniscectomy between 6 and 
12 months. At 6 months, 67.1% of the patients 
assigned to arthroscopic partial meniscectomy 
had an improvement of at least 8 points in the 
WOMAC physical-function score and had not 
crossed over to the other study treatment, as 
compared with 43.8% of patients assigned to the 
physical-therapy group (P = 0.001). Patients in 
the physical-therapy group who crossed over and 
underwent arthroscopic partial meniscectomy 
during the first 6 months had WOMAC physical-
function scores at 12 months that were similar 
to those of patients assigned to the arthroscopic-
partial-meniscectomy group (Fig. 2C). The pro-
portion of patients who crossed over from physi-
cal therapy to arthroscopic partial meniscectomy 







































































































































PT, crossover <3 mo
PT, crossover 3–6 mo
PT, crossover >6 mo
APM
PT, no crossover
PT, crossover <3 mo
PT, crossover >6 mo
PT, crossover 3–6 mo
Figure 2. Scores on the WOMAC Physical-Function 
Scale and KOOS Pain Scale over the 12-Month Follow-
up Period.
Panel A shows the scores on the physical-function scale 
of the Western Ontario and McMaster Universities  
Osteoarthritis Index (WOMAC), and Panel B shows 
the scores on the pain scale of the Knee Injury and  
Osteoarthritis Outcome Scale (KOOS); scores on both 
scales range from 0 to 100, with higher scores indicating 
more severe symptoms. I bars indicate 95% confidence 
intervals. Panel C shows WOMAC physical-function 
scores in the APM group and in the PT group accord-
ing to crossover status. The asterisk indicates that nine 
patients assigned to APM did not undergo surgery.
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general, the patients assigned to receive physical 
therapy alone who crossed over to surgery did not 
have substantial improvement in functional status 
during the period from randomization until the 
time of crossover (Fig. 2C).
In the physical-therapy group, patients were 
scheduled for an average of 9.3 physical-therapy 
visits and attended an average of 8.4 visits (90.6%). 
In the arthroscopic-partial-meniscectomy group, 
patients were scheduled for an average of 7.4 
visits and attended 6.9 visits (92.9%). In the 
physical-therapy group, 21 patients (12.4%) re-
ceived intraarticular glucocorticoid injections, as 
did 9 patients (5.6%) in the arthroscopic-partial-
meniscectomy group.
The between-group difference in functional 
improvement from baseline to 6 months did not 
differ significantly according to the Kellgren–
Lawrence grade of radiographic severity (P = 0.13 
for interaction) (Table 3 in the Supplementary 
Appendix).
Adverse Events
There were no significant between-group dif-
ferences in the frequencies of overall or specific 
adverse events. Over the 12-month period of follow-
up, serious adverse events occurred in 3 partici-
pants assigned to arthroscopic partial meniscec-
tomy and 2 participants assigned to physical 
therapy alone (including one death in each group); 
adverse events rated as mild or moderate in sever-
ity occurred in 15 participants in the arthroscopic-
partial-meniscectomy group and 13 participants 
in the physical-therapy group (Table 3). Total 
knee replacement (coded not as an adverse event 
but rather as an indication for discontinuation 
from the study) was performed in 5 participants 
assigned to arthroscopic partial meniscectomy 
and 3 participants assigned to physical therapy 
alone (Fig. 1).
Discussion
In this seven-center randomized, controlled trial 
involving symptomatic patients 45 years of age or 
older with a meniscal tear and imaging evidence 
of mild-to-moderate knee osteoarthritis, there 
were no significant differences in the magnitude 
of improvement in functional status and pain af-
ter 6 and 12 months between patients assigned to 
arthroscopic partial meniscectomy with postopera-
tive physical therapy and patients assigned to a 
standardized physical-therapy regimen. These re-
sults were achieved with a 30% rate of crossover 
to arthroscopic partial meniscectomy at 6 months. 
At 12 months, among 169 participants (not all of 
whom provided data at the 1-year evaluation), the 
rate of crossover to surgery was 35%.
In a prior small, single-center, randomized, 
controlled trial comparing arthroscopic partial 
meniscectomy with standardized physical thera-
py for symptomatic patients with a meniscal tear 
and knee osteoarthritis, the two groups had simi-
lar functional outcomes at 6 months, and the 
similarity between the groups persisted through 
5 years of follow-up.8,9 To our knowledge, this is 
the first large, multicenter, randomized, controlled 
trial to examine the efficacy of arthroscopic par-
tial meniscectomy as compared with a standard-
ized physical-therapy regimen.










Pulmonary embolism (fatal) 1 0
Acute myocardial infarction 1 0






Pain from fall or other trauma 2 4
Tendonitis 3 0
Knee bursitis 0 1
Rupture of Baker’s cyst 1 0
Knee pain 1 1
Pain in the back, hip, or foot 2 4
Cardiovascular
Deep-vein thrombosis 2 0
Syncope 1 0




The New England Journal of Medicine 
Downloaded from nejm.org at WASHINGTON UNIV SCH MED MEDICAL LIB on March 25, 2014. For personal use only. No other uses without permission. 
 Copyright © 2013 Massachusetts Medical Society. All rights reserved. 
Meniscal Tear and Osteoarthritis
n engl j med 368;18 nejm.org may 2, 2013 1683
Surgical randomized, controlled trials present 
methodologic challenges, including crossover from 
one group to the other.24,25 To account for cross-
overs, we defined an additional outcome a priori 
in which patients were deemed to have a success-
ful treatment response if they had improvement 
of at least 8 points on the WOMAC physical-
function scale (a clinically important difference) 
and they did not cross over from their assigned 
treatment. A total of 67% of patients assigned to 
arthroscopic partial meniscectomy met this thresh-
old for success, as compared with 44% of patients 
treated with physical therapy alone. We acknowl-
edge, however, that because the treatment assign-
ments were not blinded, and because crossover 
could not occur in the arthroscopic-partial-menis-
cectomy group once the surgery had been per-
formed, this secondary analysis was vulnerable 
to bias.
Several limitations of the study warrant discus-
sion. First, because we enrolled only 26% of eli-
gible patients, our findings must be generalized 
cautiously. The most frequent reason that patients 
declined enrollment was a strong preference for 
one treatment or the other. Since patients’ prefer-
ences may be associated with treatment outcome, 
our trial may be vulnerable to selection bias. Par-
ticipating surgeons may not have referred poten-
tially eligible patients because they were uncom-
fortable randomly assigning these patients to 
treatment; this form of selective enrollment may 
also create bias.26 Second, because the trial was 
conducted in academic referral centers, the find-
ings should be generalized carefully to commu-
nity settings. Third, we did not formally assess 
the fidelity of the physical therapists or surgeons 
to the standard intervention protocols. Finally, 
our study was not blinded, since our investiga-
tive group did not consider a sham comparison 
group feasible.
These limitations notwithstanding, the results 
of our trial may help guide management in the 
care of patients with knee symptoms, a meniscal 
tear, and imaging evidence of osteoarthritis. Our 
findings suggest that both arthroscopic partial 
meniscectomy and referral to physical therapy — 
with an opportunity to consider arthroscopic par-
tial meniscectomy if substantial improvements are 
not achieved — are likely to result in considerable 
improvement in functional status and knee pain 
over a 6-to-12-month period. Given that improve-
ments in functional status and pain at 6 months 
did not differ significantly between patients as-
signed to arthroscopic partial meniscectomy and 
those assigned to physical therapy alone and that 
70% of the patients in the physical-therapy group 
did not undergo surgery, these data provide con-
siderable reassurance regarding an initial nonop-
erative strategy. It is uncertain whether patients 
who undergo arthroscopic partial meniscectomy 
are at greater risk for progression of underlying 
osteoarthritis than patients treated nonoperative-
ly.27-30 Longitudinal assessment of imaging studies 
in our trial is planned to address this question.
In summary, symptomatic patients with a 
meniscal tear and imaging evidence of mild-to-
moderate osteoarthritis who were randomly as-
signed to arthroscopic partial meniscectomy with 
postoperative physical therapy had improvements 
in functional status and pain at 6 months that 
did not differ significantly from the improvements 
in patients randomly assigned to a standardized 
physical-therapy regimen alone. However, 30% of 
patients assigned to the physical-therapy group 
crossed over to surgery in the first 6 months. 
These findings should help inform decision mak-
ing by patients and their physicians.
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